We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Smart Hydrogel Paves Way for New ‘Lollipop’ Mouth Cancer Diagnostic

By LabMedica International staff writers
Posted on 25 Mar 2024
Print article
Image: The potentially flavored ‘lollipop’ could help mouth cancer diagnosis (Photo courtesy of University of Birmingham)
Image: The potentially flavored ‘lollipop’ could help mouth cancer diagnosis (Photo courtesy of University of Birmingham)

Currently, the process of diagnosing oral cancer involves the uncomfortable step of inserting a flexible camera, attached to a tube, through the nose or mouth to take a tissue sample. This invasive procedure, which is both time-consuming and reliant on skilled professionals, could soon be replaced by a groundbreaking and patient-friendly alternative. A newly developed 'lollipop' diagnostic tool, created using innovative smart hydrogel technology, promises a quicker, more accurate, and less invasive way to diagnose mouth cancer, potentially leading to earlier detection for patients.

Researchers from the University of Birmingham (Birmingham, UK) are developing a prototype flavored ‘lollipop’ from a smart hydrogel they had developed previously. Smart hydrogels have a remarkable ability to soak up vast amounts of water while capturing larger molecules, like proteins, similar to how a net captures fish. This innovative diagnostic tool works by having patients transfer saliva into the hydrogel by sucking on the 'lollipop.' Subsequently, proteins indicative of the early stages of mouth cancer can be isolated by exposing the hydrogel to UV light, releasing the captured proteins for laboratory analysis. The biocompatible hydrogel concentrates and labels proteins with a fluorescent marker in just one step, making it ideal for diagnostics that aim to detect low-abundance proteins from small samples.

The hydrogel achieves protein capture via the fluorescent marker (fluorescein isothiocyanate or FITC), which is attached to the hydrogel by a photocleavable bond. Upon exposure to light, the protein, which is now attached to the fluorescein, gets released from the hydrogel. Early experiments demonstrated the hydrogel's ability to offer a concentration factor of 236 with a reference protein (streptavidin), and 50% of the proteins in the hydrogel were released after 100 seconds of exposure to UV light. This gel presents several advantages over current diagnostic methods by simplifying the process, requiring fewer steps than ELISA-based assays or preconcentration techniques, and operating effectively at room temperature. Its biocompatibility further allows for its application both in vitro and directly on patients, marking a significant advancement from traditional, invasive diagnostic procedures that demand medical expertise.

“Smart hydrogels have really exciting potential for diagnosing mouth cancer,” said Dr. Ruchi Gupta, Associate Professor of Biosensors at the University of Birmingham who developed the gel. “They can be easily molded into shapes as a solid to “catch” proteins in saliva, and we’re hoping that we can be the first to make a device which is much kinder for diagnosing mouth cancer for patients and easier for GPs to use.”

Related Links:
University of Birmingham

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.